Susquehanna International Group
NYMX

Susquehanna International Group’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Susquehanna International Group’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,800
Closed -$5K – 14221
2022
Q3 		$5K Sell
12,800
-400
-3% -$159 ﹤0.01% 12891
2022
Q2 		$6K Sell
13,200
-4,000
-23% -$3.68K ﹤0.01% 12596
2022
Q1 		$22K Buy
+17,200
New +$26.6K ﹤0.01% 12604
2021
Q1 		– Sell
-21,500
Closed -$53K – 13020
2020
Q4 		$53K Sell
21,500
-1,300
-6% -$2.87K ﹤0.01% 10740
2020
Q3 		$56K Buy
+22,800
New +$66.4K ﹤0.01% 10174
2020
Q2 		– Sell
-27,600
Closed -$65K – 11188
2020
Q1 		$65K Buy
27,600
+14,400
+109% +$40.4K ﹤0.01% 9559
2019
Q4 		$29K Sell
13,200
-19,600
-60% -$38.7K ﹤0.01% 9445
2019
Q3 		$60K Sell
32,800
-10,300
-24% -$18K ﹤0.01% 9734
2019
Q2 		$62K Buy
43,100
+29,700
+222% +$52K ﹤0.01% 9787
2019
Q1 		$26K Sell
13,400
-49,400
-79% -$105K ﹤0.01% 8563
2018
Q4 		$82K Sell
62,800
-252,900
-80% -$463K ﹤0.01% 8305
2018
Q3 		$777K Sell
315,700
-500
-0.2% -$1.48K ﹤0.01% 5732
2018
Q2 		$1.06M Buy
316,200
+86,400
+38% +$332K ﹤0.01% 5211
2018
Q1 		$972K Sell
229,800
-192,200
-46% -$666K ﹤0.01% 5305
2017
Q4 		$1.39M Buy
422,000
+12,200
+3% +$44.5K ﹤0.01% 4593
2017
Q3 		$1.56M Sell
409,800
-148,100
-27% -$562K ﹤0.01% 4371
2017
Q2 		$2.46M Buy
557,900
+4,800
+0.9% +$19.7K ﹤0.01% 3520
2017
Q1 		$2.01M Buy
553,100
+208,600
+61% +$686K ﹤0.01% 3717
2016
Q4 		$920K Buy
344,500
+256,200
+290% +$794K ﹤0.01% 5711
2016
Q3 		$288K Buy
88,300
+48,200
+120% +$158K ﹤0.01% 6998
2016
Q2 		$134K Sell
40,100
-20,700
-34% -$50.8K ﹤0.01% 7882
2016
Q1 		$148K Buy
60,800
+11,100
+22% +$26.2K ﹤0.01% 8221
2015
Q4 		$163K Buy
49,700
+7,000
+16% +$23.5K ﹤0.01% 8584
2015
Q3 		$147K Buy
+42,700
New +$99.4K ﹤0.01% 8937
2015
Q1 		– Sell
-13,000
Closed -$5K – 10077
2014
Q4 		$5K Sell
13,000
-29,800
-70% -$63.6K ﹤0.01% 9541
2014
Q3 		$186K Buy
42,800
+16,800
+65% +$82.3K ﹤0.01% 8745
2014
Q2 		$129K Sell
26,000
-36,800
-59% -$189K ﹤0.01% 9323
2014
Q1 		$343K Buy
+62,800
New +$364K ﹤0.01% 7382
2013
Q3 		– Sell
-25,500
Closed -$131K – 8876
2013
Q2 		$131K Buy
+25,500
New +$129K ﹤0.01% 7695

Other funds holding NYMX

DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
FCFC
First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
ODIJL
One Day In July LLC Burlington, Vermont $1.44B AUM 17.18% 1-Year Est. Return

Susquehanna International Group's NYMX Position: Q3 2023 in Review

Susquehanna International Group sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 41,914 shares — an estimated $7.96K sold.

Susquehanna International Group first reported a position in NYMX in Q2 2013 and held it in 38 quarters. The position peaked at $780K in Q1 2020. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

  • Susquehanna International Group reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
  • Susquehanna International Group sold 41,914 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $7.96K.
  • Susquehanna International Group first reported a position in Nymox Pharmaceutical Corp in Q2 2013 and held it in 38 quarters.
  • Susquehanna International Group's Nymox Pharmaceutical Corp position peaked at $780K in Q1 2020.
  • 5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.